COVID-19

Increased Reports of Neurological Manifestations Among Patients With COVID-19, Brain Abnormalities

Investigators described neurological manifestations of patients with COVID-19, analyzed cerebrospinal fluid, and assessed neuroimaging findings.

Optical Biosensor Predicts Sepsis or Severe Infection in Patients at Risk

A study examines the accuracy of a new optical biosensor point-of-care device for the detection of severe infections.

Pregnant Women Struggle with PTSD During COVID-19 Lockdown

This cross-sectional, web-based, national survey was conducted during the first month of full lockdown in Italy and participants were recruited via social networks.

The Pfizer and BioNTech mRNA Vaccine for COVID-19 Conferred 95% Protection With a Satisfactory Safety Profile

Pfizer and BioNTech release safety and efficacy data from phase 2/3 trials for their COVID-19 mRNA vaccine.

Inequities Likely to Blame for Racial Disparities of COVID-19

Further research is needed to identify possible interventions that may mitigate the racial disparities seen in COVID-19.

Atrial Fibrillation, Fulminant Myocarditis Observed in Adolescent With COVID-19

Case of a 15-year-old African American girl with COVID-19 who developed atrial fibrillation and fulminant myocarditis.

Cutaneous, Histopathologic Features of COVID-19 in Children Identified

Cutaneous and histopathologic manifestations of COVID-19 infection in a pediatric population are described.

IL-6 Inhibitors Associated With Reduced In-Hospital COVID-19 Mortality

Investigators assessed whether interleukin-6 inhibitors reduced the odds of in-hospital COVID-related mortality.

SARS-CoV-2 RNA Viral Load Dynamics and Duration of Shedding

Researchers examined duration of viral RNA shedding and viable virus shedding of SARS-CoV-2 in body fluids and compared SARS-CoV-2, SARS-CoV, and MERS-CoV viral dynamics.

FDA: SARS-CoV-2 Mutations May Impact Molecular Tests

The FDA is alerting clinical laboratory staff and health care providers regarding the risk of false negative results with any SARS-CoV-2 test if a mutation occurs in the part of the virus’ genome assessed by that test.